Prethyroidectomy care pathway (previous 12 months prior surgery in 2010), by the type of thyroid diagnosis, Sniiram, France
| Cancer | Benign nodule | Multiple nodules and goitre | Cancer/ benign nodule ratio | Cancer/ goitre ratio | |
|---|---|---|---|---|---|
| N=5979 | N=7270 | N=13 350 | |||
| Thyroid ultrasound | 80% | 84% | 82% | 1.0 | 1.0 |
| Fine-needle aspiration cytology of the thyroid | 44% | 34% | 23% | 1.3 | 1.9 |
| Thyroid scintigraphy | 18% | 21% | 22% | 0.9 | 0.8 |
| At least one of the 3 | 89% | 91% | 88% | 1.0 | 1.0 |
| TSH assay | 89% | 91% | 92% | 1.0 | 1.0 |
| T3 assay | 36% | 35% | 37% | 1.0 | 1.0 |
| T4 assay | 63% | 65% | 66% | 1.0 | 1.0 |
| Calcitonin assay | 44% | 39% | 39% | 1.1 | 1.1 |
| Calcium assay | 58% | 50% | 55% | 1.2 | 1.1 |
| No T3, T4 or TSH assay | 10% | 8% | 8% | 1.2 | 1.3 |
| ≥3 thyroid hormone deliveries | 21% | 16% | 19% | 1.3 | 1.1 |
| ≥1 endocrinology consultation | 49% | 44% | 49% | 1.1 | 1.0 |
| ≥1 ear-nose-throat specialist consultation | 43% | 49% | 43% | 0.9 | 1.0 |
Italic font denotes the sum of images or blood analysis performed before thyroidectomy. TSH, thyroid-stimuling hormone.